Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study

M Porteous; M Dunckley; S Appleton; S Catt; M Dunlop; H Campbell; A Cull

doi:10.1038/sj.bjc.6601332

Is it acceptable to approach colorectal cancer patients at diagnosis to discuss genetic testing? A pilot study

Br J Cancer. 2003 Oct 20;89(8):1400-2. doi: 10.1038/sj.bjc.6601332.

Authors

M Porteous¹, M Dunckley, S Appleton, S Catt, M Dunlop, H Campbell, A Cull

Affiliation

¹ Department of Clinical Genetics, Molecular Medicine Centre, Western General Hospital, Crewe Road South, Edinburgh EH4 2XU, UK. mary.porteous@ed.ac.uk

Abstract

In this pilot study, the acceptability of approaching 111 newly diagnosed colorectal cancer patients with the offer of genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC) was assessed. A total of 78% of participants found it highly acceptable to have the information about HNPCC brought to their attention at that time.

Publication types

Evaluation Study
Research Support, Non-U.S. Gov't

MeSH terms

Adult
Colorectal Neoplasms / diagnosis*
Colorectal Neoplasms / genetics*
Colorectal Neoplasms, Hereditary Nonpolyposis / diagnosis*
Colorectal Neoplasms, Hereditary Nonpolyposis / genetics*
Female
Genetic Testing*
Humans
Male
Middle Aged
Patient Compliance
Patient Participation*
Patient Satisfaction
Risk Factors